Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview

被引:37
作者
Dorian, P [1 ]
Newman, D [1 ]
机构
[1] St Michaels Hosp, Div Cardiol, Toronto, ON M5B 1W8, Canada
来源
EUROPACE | 2000年 / 2卷 / 04期
关键词
antiarrhythmic agents; refractory periods; rate dependence;
D O I
10.1053/eupc.2000.0114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prolongation of the cardiac action potential and refractoriness (class III effect) is a potentially beneficial electrophysiological mechanism of action. However, this effect may be diminished or eliminated at rapid heart rates, so-called 'reverse rate dependence' of prolongation of repolarization, Action potential duration normally shortens as heart late increases, due to increases in outward repolarizing currents, and/or decreases in inward depolarizing currents. The assessment of the effect of drugs on action potential duration is complicated by inter-species differences in ionic currents mediating repolarization, heterogeneity within the heart in repolarizing currents, and differential effect of drugs in different species, during differing experimental conditions, and at different rates of stimulation. In general, most drugs which predominantly block the I-Kr repolarizing current exhibit reverse rate-dependent effects on cardiac repolarization. Drugs or combinations of drugs which produce multiple ionic channel blocks and possibly those which block the I-Ks current, may be less prone to this potentially undesirable effect. (Europace 2000; 2: 277-285) (C) 2000 The European Society of Cardiology.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 69 条
[1]   METOPROLOL VERSUS SOTALOL IN THE TREATMENT OF SUSTAINED VENTRICULAR-TACHYCARDIA [J].
ANTZ, M ;
CAPPATO, R ;
KUCK, KH .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (04) :627-635
[2]   HETEROGENEITY WITHIN THE VENTRICULAR WALL - ELECTROPHYSIOLOGY AND PHARMACOLOGY OF EPICARDIAL, ENDOCARDIAL, AND M-CELLS [J].
ANTZELEVITCH, C ;
SICOURI, S ;
LITOVSKY, SH ;
LUKAS, A ;
KRISHNAN, SC ;
DIDIEGO, JM ;
GINTANT, GA ;
LIU, DW .
CIRCULATION RESEARCH, 1991, 69 (06) :1427-1449
[3]  
Baskin EP, 1998, J PHARMACOL EXP THER, V285, P135
[4]   Rate- and site-dependent effects of propafenone, dofetilide and the new IKs-blocking agent chromanol 293b on individual muscle layers of the intact canine heart [J].
Bauer, A ;
Becker, R ;
Freigang, KD ;
Senges, JC ;
Voss, F ;
Hansen, A ;
Müller, M ;
Lang, HJ ;
Gerlach, U ;
Busch, A ;
Kraft, P ;
Kübler, W ;
Schöls, W .
CIRCULATION, 1999, 100 (21) :2184-2190
[5]  
BLOCHTHOMSEN PE, 1998, CLIN CARDIOL, V21, P53
[6]   Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes [J].
Bosch, RF ;
Gaspo, R ;
Busch, AE ;
Lang, HJ ;
Li, GR ;
Nattel, S .
CARDIOVASCULAR RESEARCH, 1998, 38 (02) :441-450
[7]   Amiodarone interaction with β-blockers -: Analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases [J].
Boutitie, F ;
Boissel, JP ;
Connolly, SJ ;
Camm, AJ ;
Cairns, JA ;
Julian, DG ;
Gent, M ;
Janse, NJ ;
Dorian, P ;
Frangin, G .
CIRCULATION, 1999, 99 (17) :2268-2275
[8]   CHANGES IN THE ELECTRICAL-ACTIVITY OF DOG CARDIAC PURKINJE-FIBERS AT HIGH HEART-RATES [J].
BOYETT, MR ;
FEDIDA, D .
JOURNAL OF PHYSIOLOGY-LONDON, 1984, 350 (MAY) :361-391
[9]   Combined potassium and calcium channel antagonistic activities as a basis for neutral frequency dependent increase in action potential duration: comparison between BRL-32872 and azimilide [J].
Bril, A ;
Forest, MC ;
Cheval, B ;
Faivre, JF .
CARDIOVASCULAR RESEARCH, 1998, 37 (01) :130-140
[10]   Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT [J].
Cairns, JA ;
Connolly, SJ ;
Roberts, R ;
Gent, M .
LANCET, 1997, 349 (9053) :675-682